<?xml version="1.0" encoding="UTF-8"?>
<ref id="B96-ijms-21-03492">
 <label>96.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yannaki</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Papadopoulou</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Athanasiou</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kaloyannidis</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Paraskeva</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Bougiouklis</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Palladas</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Yiangou</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Anagnostopoulos</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats</article-title>
  <source>Arthritis Rheum.</source>
  <year>2010</year>
  <volume>62</volume>
  <fpage>3277</fpage>
  <lpage>3288</lpage>
  <pub-id pub-id-type="doi">10.1002/art.27690</pub-id>
  <pub-id pub-id-type="pmid">20722034</pub-id>
 </element-citation>
</ref>
